Merck KGaA to Acquire Silence Therapeutics for $1.3 Billion
Merck KGaA, Darmstadt, Germany, has agreed to acquire Silence Therapeutics, a UK-based biotechnology company, in an…
Trending
- Merck KGaA to Acquire Silence Therapeutics for $1.3 Billion
- Lilly’s Omvoh Meets Phase 3 Goal in Pediatric Ulcerative Colitis
- EyePoint’s DURAVYU Fails Main Endpoint in Phase 3 Wet AMD Trial
- As AI and ICH M15 Transform Drug Development, Industry Leaders Convene to Advance Model-Informed Decision Making
- Estuary Biotherapeutics Launches with $103 Million for Kidney Gene Therapies
- Viatris Wins FDA Approval for RYZUMVI to Treat Presbyopia
- Roche Wins FDA Approval for Enspryng in Thyroid Eye Disease
- Roche Wins FDA Approval for Enspryng in Thyroid Eye Disease
- FDA Expands ANKTIVA Approval for Papillary Bladder Cancer
- Vir Biotechnology and Gilead Partner on Solid Tumor T-Cell Engagers
Top Headlines
Lilly’s Omvoh Meets Phase 3 Goal in Pediatric Ulcerative Colitis
Eli Lilly and Company has announced positive Phase 3 clinical trial results for Omvoh (mirikizumab-mrkz) in…
EyePoint’s DURAVYU Fails Main Endpoint in Phase 3 Wet AMD Trial
EyePoint, Inc. (NASDAQ: EYPT) has announced topline results from its LUCIA Phase 3 clinical trial evaluating…
Estuary Biotherapeutics Launches with $103 Million for Kidney Gene Therapies
Estuary Biotherapeutics has launched with $103 million in committed financing to develop targeted gene therapies…
Viatris Wins FDA Approval for RYZUMVI to Treat Presbyopia
Viatris has received approval from the U.S. Food and Drug Administration (FDA) for RYZUMVI (phentolamine ophthalmic…
Roche Wins FDA Approval for Enspryng in Thyroid Eye Disease
Roche has received approval from the U.S. Food and Drug Administration (FDA) for Enspryng (satralizumab) to treat…
Featured Event
Clinical Trials
EyePoint’s DURAVYU Fails Main Endpoint in Phase 3 Wet AMD Trial
EyePoint, Inc. (NASDAQ: EYPT) has announced topline results from its LUCIA Phase 3 clinical trial evaluating DURAVYU (vorolanib intravitreal insert)…
Roche Wins FDA Approval for Enspryng in Thyroid Eye Disease
Roche has received approval from the U.S. Food and Drug Administration (FDA) for Enspryng (satralizumab) to treat adults with thyroid eye disease…
Wainua Misses Primary Endpoint in ATTR-CM Phase III Trial
AstraZeneca and Ionis Pharmaceuticals have announced that their Phase III CARDIO-TTRansform trial evaluating Wainua (eplontersen) in patients with…
Boehringer Advances Phase III Cancer Precision Medicine Trials
Boehringer Ingelheim has announced the launch of three Phase III clinical trials aimed at advancing precision oncology for patients with some of the…
uniQure Reports Early Promise for Epilepsy Gene Therapy
uniQure has reported encouraging early clinical results from its experimental gene therapy AMT-260, offering new hope for patients living with…
Massive Bio, Optellum Partner to Advance Lung Cancer Trial Access
Massive Bio and Optellum have announced a strategic collaboration designed to connect early lung cancer detection with faster access to clinical…
Fast shipping, security and absolute privacy is our main goal Viagra-Buy.com/ savings on their medication from a licensed and certified pharmacy.
The best pharmacy in america Viagra-Buy.com Fast delivery, best prices and for real men
Zealand Pharma and Generate Biomedicines Partner on AI-Designed Obesity Treatments
Zealand Pharma and Generate Biomedicines have announced a strategic collaboration to develop AI-designed protein…
Cognizant Extends Gilead Partnership to Expand AI-Enabled DevOps
Cognizant has extended its partnership with Gilead Sciences for five years to support the biopharmaceutical…
Drug Research
Roche Wins FDA Approval for Enspryng in Thyroid Eye Disease
Roche has received approval from the US Food and Drug Administration (FDA) for Enspryng (satralizumab) to treat…
AstraZeneca Invests $2B in Summit Therapeutics for Cancer Research
AstraZeneca has agreed to invest $2 billion in Summit Therapeutics to support the development of ivonescimab and…
Sentynl, Mereo Partner to Advance Oral AATD Lung Disease Therapy
Sentynl Therapeutics, a U.S.-based biopharmaceutical company and wholly owned subsidiary of Zydus Lifesciences, has…
Latus Bio Raises $97 Million to Advance Gene Therapies
Latus Bio, Inc. has secured $97 million in Series A financing to accelerate the development of its gene therapy…
UK Streamlines Drug Approvals to Accelerate Patient Access
The Medicines and Healthcare products Regulatory Agency (MHRA) and National Institute for Health and Care…
Manufacturing
SK pharmteco Invests $200M to Expand U.S. Drug Manufacturing
SK pharmteco has announced a five-year investment of more than $200 million to expand and upgrade its development…
Varda Raises $251M to Scale Space-Based Pharmaceutical Manufacturing
Varda Space Industries has raised $251 million in a Series D financing round to expand its work in space-based…
Genentech Plans $750 Million Device Manufacturing Facility in Oregon
Genentech, a member of the Roche Group, plans to invest approximately $750 million to build a new device…
Fujifilm and Taiho Partner on Next-Generation ADC Manufacturing
FUJIFILM Corporation and Taiho Pharmaceutical have formed a strategic partnership to advance manufacturing…
Cellares and SonomaBio Partner on Automated Treg Cell Therapy Manufacturing
Cellares and Sonoma Biotherapeutics have announced a new collaboration to automate the manufacturing of…
Cellares, TScan Partner on Automated TSC-101 Manufacturing
Cellares and TScan Therapeutics have entered into a strategic agreement to evaluate automated clinical…
Fujifilm Expands Stem Cell Manufacturing in Wisconsin
FUJIFILM Cellular Dynamics has inaugurated a new headquarters and induced pluripotent stem cell (iPSC) development…
Piramal, Ajinomoto Partner to Advance ADC Manufacturing Capabilities
Piramal Pharma Solutions and Ajinomoto Bio-Pharma Services have announced a strategic collaboration aimed at…
Diseases
Estuary Biotherapeutics Launches with $103 Million for Kidney Gene Therapies
Estuary Biotherapeutics has launched with $103 million in committed financing to develop targeted gene therapies…
Roche Wins FDA Approval for Enspryng in Thyroid Eye Disease
Roche has received approval from the US Food and Drug Administration (FDA) for Enspryng (satralizumab) to treat…
Tenaya and Alnylam Partner to Discover New Genetic Targets for Heart Disease
Clinical-stage biotechnology company Tenaya Therapeutics has announced a new research collaboration with RNA…
AstraZeneca, CSPC Partner on Next-Generation Obesity Therapies
AstraZeneca has strengthened its weight management and metabolic disease pipeline through a new strategic…
China Approves ENHERTU for Second-Line HER2-Positive Gastric Cancer
China’s National Medical Products Administration (NMPA) has approved ENHERTU® (trastuzumab deruxtecan) for the…
InterAx, Alveus Partner to Advance Next-Generation Obesity Therapy
InterAx Biotech Ltd and Alveus Therapeutics Inc. have entered into a strategic research collaboration and licensing…
